2.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.09
Aprire:
$3.1
Volume 24 ore:
636.15K
Relative Volume:
1.14
Capitalizzazione di mercato:
$213.05M
Reddito:
$115.02M
Utile/perdita netta:
$-68.73M
Rapporto P/E:
-3.1741
EPS:
-0.9357
Flusso di cassa netto:
$-53.22M
1 W Prestazione:
-6.90%
1M Prestazione:
+8.00%
6M Prestazione:
-10.27%
1 anno Prestazione:
-12.90%
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OSUR
Orasure Technologies Inc
|
2.97 | 213.05M | 115.02M | -68.73M | -53.22M | -0.9357 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-03 | Ripresa | Evercore ISI | In-line |
| 2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Iniziato | Evercore ISI | Outperform |
| 2020-08-10 | Iniziato | Citigroup | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
| 2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Iniziato | Lake Street | Buy |
| 2020-04-21 | Ripresa | Stephens | Equal-Weight |
| 2018-10-23 | Ripresa | Raymond James | Mkt Perform |
| 2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Downgrade | Jefferies | Buy → Hold |
| 2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Reiterato | Mizuho | Buy |
| 2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Reiterato | Mizuho | Buy |
| 2014-06-12 | Reiterato | Canaccord Genuity | Buy |
| 2014-06-11 | Reiterato | Mizuho | Buy |
| 2012-12-21 | Iniziato | Mizuho | Buy |
| 2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Aug Fed Impact: Is OraSure Technologies Inc attractive for institutional investorsExit Point & Daily Volume Surge Signals - baoquankhu1.vn
Former VA head departs OraSure board - WFMZ.com
OraSure Technologies 2025 Annual Report: Diagnostic Products, Genomic Solutions, and Global Expansion - Minichart
[10-K] ORASURE TECHNOLOGIES INC Files Annual Report | OSUR SEC FilingForm 10-K - Stock Titan
Momentum Shift: Is OraSure Technologies Inc being accumulated by smart moneyWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
OraSure gains on report investor threatens `adversarial' path on buyout - MSN
Fed Meeting: Why is OraSure Technologies Inc stock going upJuly 2025 Gainers & Long Hold Capital Preservation Plans - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above 200 Day Moving AverageHere's What Happened - MarketBeat
OraSure Technologies Developments Capture Healthcare Market Interest - Kalkine Media
OraSure Technologies Announces Resignation of Board Member Shulkin - TipRanks
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - simplywall.st
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Announces Fourth Quarter 2025 Financial Results - The Manila Times
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com Australia
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):